Ram K Mishra Selected Research

Ram K Mishra Research Topics

Disease

22	Schizophrenia (Dementia Praecox) 10/2021 - 09/2002
6	Parkinson Disease (Parkinson's Disease) 01/2021 - 01/2003
5	Mental Disorders (Mental Disorder) 01/2022 - 09/2011
3	Tardive Dyskinesia 09/2011 - 12/2004
2	Neoplasms (Cancer) 11/2020 - 11/2016
2	Movement Disorders (Movement Disorder) 01/2018 - 08/2011
2	Psychotic Disorders (Schizoaffective Disorder) 01/2017 - 06/2010
2	Neuroblastoma 11/2009 - 12/2005
1	Infections 01/2022
1	Treatment-Resistant Depressive Disorder 01/2022
1	Dyskinesias (Dyskinesia) 01/2021
1	Stroke (Strokes) 01/2020
1	Genetic Predisposition to Disease (Genetic Predisposition) 09/2015
1	Catalepsy 05/2014
1	Central Nervous System Diseases (CNS Diseases) 11/2009
1	Bipolar Disorder (Manic Depressive Psychosis) 04/2005

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2002
9	3- (N- prolylamine)- 2- oxo- 1- pyrrolidineacetamideIBA 10/2021 - 12/2005
9	Synapsins (Synapsin I)IBA 01/2019 - 09/2002
7	Haloperidol (Haldol)FDA LinkGeneric 01/2018 - 09/2002
7	Antipsychotic Agents (Antipsychotics)IBA 01/2017 - 12/2004
6	Dopamine (Intropin)FDA LinkGeneric 01/2020 - 01/2003
5	Therapeutic UsesIBA 10/2021 - 05/2014
5	PhosphoproteinsIBA 01/2019 - 08/2009
5	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 05/2013 - 01/2011
5	Messenger RNA (mRNA)IBA 01/2013 - 08/2009
4	CatecholaminesIBA 09/2013 - 11/2009
3	CurcuminIBA 11/2020 - 08/2011
3	Phencyclidine (Angel Dust)IBA 01/2019 - 12/2007
3	MSH Release-Inhibiting Hormone (MIF-I)IBA 01/2018 - 01/2003
3	PeptidomimeticsIBA 04/2013 - 10/2007
3	glycine amideIBA 01/2011 - 12/2005
2	N-Methylaspartate (NMDA)IBA 01/2019 - 01/2018
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2019 - 01/2011
2	Amphetamine (Amfetamine)FDA LinkGeneric 01/2018 - 03/2013
2	phenyl-N-tert-butylnitroneIBA 09/2011 - 12/2004
2	mortalinIBA 06/2010 - 11/2009
1	Ketamine FDA LinkGeneric 01/2022
1	Anesthetics (Anesthetic Agents)IBA 01/2022
1	HydrogelsIBA 10/2021
1	ParaquatIBA 01/2021
1	TunicamycinIBA 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2020
1	Nerve Growth Factors (Neurotrophins)IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Complementary DNA (cDNA)IBA 01/2020
1	PolyelectrolytesIBA 11/2016
1	Ethylene Glycol (Monoethylene Glycol)IBA 05/2014
1	LectinsIBA 05/2014
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 05/2014
1	polyethylene glycol-poly(lactide-co-glycolide)IBA 05/2014
1	Protein Isoforms (Isoforms)IBA 05/2013
1	Dizocilpine Maleate (Dizocilpine)IBA 03/2013
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2013
1	Dopamine Receptors (Dopamine Receptor)IBA 08/2011
1	prolylleucineIBA 01/2011
1	Dopamine Agonists (Dopamine Agonist)IBA 11/2009
1	Oxidopamine (6 Hydroxydopamine)IBA 10/2007
1	Apomorphine FDA Link 10/2007
1	Melanocyte-Stimulating Hormones (MSH)IBA 10/2007
1	Trifluoroacetic Acid (Trifluoroacetate)IBA 10/2007
1	Free RadicalsIBA 12/2004
1	Serotonin ReceptorsIBA 01/2003
1	Loxapine (Loxitane)FDA LinkGeneric 01/2003

Therapy/Procedure

2	Therapeutics 04/2015 - 03/2013
1	Intranasal Administration 01/2022